🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will compare the pharmacokinetics of LCQ908 in subjects with var...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01594957
Treatments Being Tested
This study will assess safety, tolerability, and effect of LCQ908 on blood ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-05
Trial ID
NCT01146522
The purpose of this study was to determine whether LCQ908 effectively lower...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06
Trial ID
NCT01811472
The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Status
Completed
Location
Advanced Clinical Research-Meridian
Start Date
2020-09-22
Trial ID
NCT04620161
This is a study designed to evaluate the potential for the pradigastat (LCQ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-12
Trial ID
NCT01474434
Treatments Being Tested
This study will compare the pharmacokinetics of LCQ908 in subjects with var...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05
Trial ID
NCT01558323
Treatments Being Tested
This study is to determine a dose response signal for LCQ908 monotherapy an...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01594983
Treatments Being Tested
This is a proof of concept study, designed to look at the safety and antivi...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01387958
This study will assess the effect of LCQ when added to metformin....
Status
Completed
Location
Clinical Research Advantage
Start Date
2009-04
Trial ID
NCT00901979
This study was to determine long-term safety and tolerability, and continue...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-02
Trial ID
NCT01589237
Treatments Being Tested